Table IV.
Univariate and multivariate analysisa of clinicopathological parameters in association with overall survivalb.
| Overall survival | ||||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Age, years | 0.734 | 0.887 | ||
| ≤55 | 1 | 1 | ||
| >55 | 0.855 (0.340–2.123) | 0.932 (0.347–2.485) | ||
| FIGO stage | <0.0001 | <0.0001 | ||
| I/II | 1 | 1 | ||
| III/IV | 21.611 (6.155–136.684) | 30.114 (7.226–205.835) | ||
| Histological type | 0.0237 | 0.232 | ||
| Serous | 1 | 1 | ||
| Non-serous | 0.348 (0.138–0.865) | 1.938 (0.647–5.734) | ||
| Chemotherapy | 0.489 | 0.182 | ||
| Taxane plus platinum | 1 | 1 | ||
| Others | 1.587 (0.367–4.822) | 2.821 (0.576–10.832) | ||
| Surgery | 0.0143 | 0.199 | ||
| Full staging/complete | 1 | 1 | ||
| Non-staging/debulking | 3.294 (1.258–10.207) | 2.038 (0.698–6.906) | ||
| HS1 | 0.0320 | 0.0187 | ||
| Low | 1 | 1 | ||
| High | 3.013 (1.093–10.573) | 3.539 (1.221–12.811) | ||
a
Cox hazard model
b
170 patients with full clinical information including age, FIGO stage, histological type, type of chemotherapy and type of surgery. HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; HS1, hematopoietic lineage cell-specific protein 1.